Companies Producing Edibles Containing CBD and Delta-8 THC Receive New Warning Letters from the FDA

The FDA has recently issued new warning letters to companies that produce CBD and Delta-8 THC edibles. This is due to the fact that these products are not adequately labeled and may be misleading to consumers. The FDA is urging companies to make sure that their products are properly labeled and tested before they are sold. Labeling requirements include specifying the amount of CBD or Delta-8 THC in each serving, validated through a third-party testing laboratory, as well as any other active ingredients. Products that do not meet these standards may be subject to recall or disposal. Consumers should always check the labels of CBD and Delta-8 THC products before purchasing them to make sure they are getting what they expect.

FDA cites compliance and safety concerns in warning letters pertaining to CBD and Delta-8 THC edibles

The U.S. Food and Drug Administration (FDA) recently issued warning letters to companies producing Delta-8 THC and cannabidiol (CBD)-infused edibles brands, citing compliance issues and product safety concerns. The warnings covered infractions such as failure to conduct lab testing on the products, failure to include required labeling information, and misrepresentation or misbranding of a food product in violation of the Federal Food, Drug, and Cosmetic Act. FDA Commissioner Stephen Hahn noted that "The production of edibles for sale often includes more than the extraction and infusion of cannabinoids into foods," stressing that safety compliance is essential for all aspects of production. Clearly, compliance with the law is an important issue when it comes to CBD and delta-8 THC edibles and other cannabis-related products - taking shortcuts can cost you dearly. Companies must remain mindful of their legal obligations in order to ensure safe and effective products for consumers. Failure to comply with mandated safety regulations ultimately places consumers at risk, making strict compliance requirements non-negotiable when it comes to CBD edible products.  The FDA’s new warning letters are a helpful reminder that compliance with the law should be taken seriously by all involved in the production process - not just those producing final products but also suppliers, testers, marketers and everyone in between.  A commitment to compliance isn't just smart business practice; it's crucial for promoting consumer safety now and into the future.

These products are not approved by the FDA and may be unsafe

People often choose edibles and other products which are not regulated by the Food and Drug Administration (FDA) in the belief that they may be safer or better than those approved by the agency. However, it is important to remember that edibles — along with any other food, drinks, and dietary supplements — are only safe if they have been thoroughly tested and approved by the FDA. These edibles may contain harmful chemicals or unknown ingredients which can cause side effects such as nausea, headaches, or worse. Furthermore, edibles which do not meet FDA approval often violate safety standards set forth by the agency and may pose a risk of contamination due to improper storage or handling during production. Therefore, it is essential to make sure that any edible purchased is tested and approved by the FDA to ensure its safety and quality. Doing so will help protect people from potentially dangerous edibles and provide them with peace of mind when consuming food products.

The companies have 15 days to respond to the warning letters

Upon receiving a warning letter from the government, companies have fifteen days to respond. This response must include information about the measures they are taking to bring their product into compliance with applicable standards. If the company fails to respond within the allocated timeframe, penalties may be imposed. These penalties may include restrictions on their ability to continue manufacturing similar products or requirements for additional lab testing in order to verify safety and efficacy claims. Companies that don't take the initiative to ensure regulatory compliance should utilize this 15-day window of opportunity to respond and demonstrate that they are making an effort to improve their operations and comply with regulations. Otherwise, failure to act could have severe repercussions for failing businesses. Fortunately, those who put forth preemptive efforts can avoid penalties and maintain compliance with federal regulations.  It is essential for companies to adhere to these warnings in order to prevent any further enforcement action by the government.

If they don't comply, their products may be seized or banned from being sold in the US

Non-compliance with US law can come with serious consequences for both businesses and individuals. Companies may find their products raided, their licenses revoked, and/or hefty fines imposed if they do not adhere to established regulations. The government also has many other tools at its disposal: products can be seized from warehouses and distributors, imported goods may be denied entry into the US, and orders against selling certain items within the US can be issued. In extreme cases, a company may have its US operations shut down altogether. Businesses should therefore take any violations of US law very seriously; if they don't comply, their products may end up being banned completely from the American market. Such drastic measures are certainly not taken lightly, so those hoping to stay in business must act quickly and decisively to adhere to all applicable laws. Otherwise, the repercussions could be significant.

Consumers should be aware of these risks before purchasing these products

Consumers are increasingly turning to online vendors, suppliers, and manufacturers in order to purchase a variety of products and services. However, there are risks associated with online purchasing, and it is important that consumers are aware of these potential issues before they make any decisions. For starters, online vendors may not be located within the consumer's jurisdiction. This can create legal difficulties if problems arise with the product or service purchased. Additionally, online suppliers and manufacturers may not have rigorous safety standards in place that would protect consumers from experiencing issues such as defective products or contaminated materials. Finally, online promotions and sale prices could be misleading or outright fraudulent. By understanding these potential risks before engaging with online vendors, suppliers, and manufacturers, consumers can do their best to ensure a successful transaction with minimal difficulty.

The FDA will continue to monitor the situation and take action as needed

The U.S. Food and Drug Administration (FDA) is committed to ensuring the safety and security of the public's food supply. To maintain these strict standards, the agency will continue to monitor conditions in the food industry and take action as needed. The FDA has numerous programs and protocols in place to evaluate potential risks to consumers. These include certificates of analysis, random testing, and audits of production plants and warehouses throughout the year. Additionally, FDA personnel may be called upon upon for field inspections or recall investigations whenever necessary. Ultimately, the FDA is dedicated to providing a safe and wholesome food supply for all American citizens, and it will remain vigilant in monitoring any developments that may pose a threat to this goal.  By continually staying abreast of the situation, they can ensure that any problems are caught early and resolved appropriately.  Such efforts help make sure that all products available on the market meet mandated safety requirements at all times.  It is essential for everyone's health, comfort, and peace of mind that this vigilance remains ongoing.

The FDA has issued new warning letters to companies making CBD and Delta-8 THC edibles. These products are not approved by the FDA and may be unsafe. The companies have 15 days to respond to the warning letters. If they don't comply, their products may be seized or banned from being sold in the US. Consumers should be aware of these risks before purchasing these products. The FDA will continue to monitor the situation and take action as needed. Contact us today to ensure your quality products are tested and safe.

The Cannabinoids Guide

This complete cannabinoid guide covers major and minor cannabinoids, how they work in the body, and highlights the top compounds brands and operators must test for today.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

The Cannabinoid Guide

The definitive resource on leading major and minor cannabinoids, how they work in the body, and what to test for.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Related Blogs

February 2, 2023

A Guide to Delta-8 vs. THCOa: Extraction, Products, Safety, Legality, Testing & More

Comparing Delta-8 THC and THCOa’s chemistry, effects, potency, and extraction methods.

Elena Schmidt

January 30, 2023

ACS Laboratory Receives 82 Emerald Badges for Exemplary Hemp and Cannabis Test Results, More Than Any Laboratory in the USA

Recently Awarded 21 Emerald Test Proficiency Badges for 2022, ACS has Reaffirmed its Position as the Most Trusted Third-party Hemp and Cannabis Testing Provider

ACS Laboratory

January 25, 2023

Comparing Exotic Cannabinoids: Delta-9 THC vs. Delta-8, Delta-10, HHC, HHCP, THC-O (THCOa), & THCP

The main difference between exotic cannabinoids and Delta-9 THC is their molecular structures, psychoactive intensity, and legality.

Elena Schmidt

December 29, 2022

A Guide to Delta-8 vs. HHC: Extraction, Products, Safety, Legality, Testing & More

Delta-8 THC is a mildly euphoric psychoactive isomer of Delta-9 THC. HHC belongs to a completely different chemical class known as hexahydrocannabinol. Learn more.

Elena Schmidt

January 19, 2023

Amanita Muscaria Part II: Active Ingredients, Effects, Nutrition & Legality

Exploring amanita muscaria’s psychoactive effects, toxic potential, edible preparation, and legality in the US and Canada.

Masha Ty

January 13, 2023

Cannabis Concentrates 101: A Guide to Terms, Usage, Potency, and Testing

Explaining the differences between cannabis concentrate types–from potency to usage to equipment and safety.

Elena Schmidt

January 5, 2023

Functional Mushrooms: Exploring Lion’s Mane, Cordyceps, and Reishi Benefits & Uses

Reviewing functional mushroom benefits, research, and top products, with a focus on reishi, lion’s mane, and cordyceps.

Masha Ty

January 3, 2023

Terpene Tuesdays: Everything You Need to Know About Farnesene Flavor, Fragrance, and Benefits

Farnesene is a cannabis terpene known as sesquiterpenes and is thought to have sedative and regulating effects on the human body and mood.

Elena Schmidt

December 9, 2022

INTERVIEW: Live Rosin Delta-8: How It's Made, Effects, Safety & Quality

Live rosin delta 8 is a cannabis concentrate made from frozen plant material and manufactured delta-8 extract. Learn more.

December 20, 2022

Terpene Tuesdays: Everything You Need to Know About Camphene Flavor, Fragrance, and Benefits

Research suggests that camphene possesses anti-microbial and antiviral properties, provides coughing relief, and may even be able to prevent heart disease.

Elena Schmidt

December 16, 2022

Amanita Muscaria (Fly Agaric): History & Toxicology of the Most Misunderstood Mushroom

Amanita mushrooms are fully legal in the United States and have a long history of use. Discovery Amanita mythology and toxicology in this ACS blog.

Masha Ty

December 14, 2022

Visit the New and Improved ACS Laboratory Website

Enhanced education, intuitive navigation, mushroom program launch, compliance updates, and more!

Elena Schmidt

December 8, 2022

Companies Producing Edibles Containing CBD and Delta-8 THC Receive New Warning Letters from the FDA

FDA recently issued new warning letters to companies that produce CBD and Delta-8 THC edibles.

December 1, 2022

THCP: Guide to THCP Effects, Products, Legality, Testing, and More

THCP has a 30X stronger binding affinity to ECS receptors than Delta-9 THC, marijuana's most abundant and powerful psychoactive agent.